NCT05602571

Brief Summary

The aim of this study is to determine the effectiveness of adding PRP or Sham PRP injection to ESWT treatment in patients with lateral epicondylitis on pain, muscle strength, functional activities, quality of life and work activities, and to determine the superiority of the treatments over each other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2022

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

October 27, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 2, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2024

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

October 27, 2022

Last Update Submit

January 5, 2025

Conditions

Keywords

Lateral EpicondylitisExtracorporeal Shockwave Therapy (ESWT)Platelet-Rich Plasma (PRP)

Outcome Measures

Primary Outcomes (1)

  • Change from baseline visual analog scale (VAS) elbow pain at 4th and 12th week

    Pain intensity was measured with visual analogue scale for pain (0-10 mm; 0 means no pain, 10 means severe pain) which is used to measure musculoskeletal pain with very good reliability and validity. The patient will be asked to score rest, movement, and nighttime pain.

    baseline and 12th week

Secondary Outcomes (5)

  • Change from baseline Handgrip strength at 4th and 12th week

    baseline and 12th week

  • Change from baseline Quick Disabilities of the Arm, Shoulder and Hand Score (Quick DASH) at 4th and 12th week

    baseline and 12th week

  • Change from baseline quality of life (Short Form 36 (SF-36)) at 4th and 12th weeks

    baseline and 12th week

  • Change from baseline Ultrasonographic examination at 4th and 12th weeks

    baseline and 12th week

  • Change from baseline upper extremity muscle strength with isokinetic device at 4th and 12th weeks

    baseline and 12th week

Study Arms (3)

ESWT+Exercise

EXPERIMENTAL

Home exercise program including stretching and eccentric strengthening exercises twice a day for 3 months + 3 sessions of ESWT once a week for 3 weeks.

Other: ESWT+Exercise

PRP+ESWT+Exercise

ACTIVE COMPARATOR

Home exercise program including stretching and eccentric strengthening exercises twice a day for 3 months + 3 sessions of ESWT once a week for 3 weeks + PRP injection

Procedure: PRP+ESWT+Exercise

Sham PRP+ESWT+Exercise

SHAM COMPARATOR

Home exercise program including stretching and eccentric strengthening exercises twice a day for 3 months + 3 sessions of ESWT once a week for 3 weeks + Sham PRP injection

Procedure: Sham PRP+ESWT+Exercise

Interventions

Radial ESWT treatment will be applied to patients for 3 weeks, once a week for a total of 3 sessions. Radial shock waves will be applied in circular motions by applying gel on the epicondylar area where the most pain and sensitivity is. In each session, 8 Hz, 2.0 bar, 2000 beats will be applied. Therapeutic Exercise: All patients will be taught a home exercise program including stretching and eccentric strengthening exercises by an experienced physiotherapist. The eccentric exercises consisted of the following: three sets of 10 repetitions for wrist and elbow flexion; two sets of 10 repetitions for wrist extension strengthening, starting with 50% of maximum strength and density and increasing the resistance each week; and finally, two sets of 10 repetitions for the wrist flexor and extensor muscle groups comprising 20s of stretching and 10s of relaxing using the unaffected hand. Exercise program will be done twice a day for 3 months.

ESWT+Exercise

Radial ESWT treatment will be applied to patients for 3 weeks, once a week for a total of 3 sessions. Radial shock waves will be applied in circular motions by applying gel on the epicondylar area where the most pain and sensitivity is. In each session, 8 Hz, 2.0 bar, 2000 beats will be applied. Therapeutic Exercise: All patients will be taught aforementioned home exercise program. Exercise program will be done twice a day for 3 months. Procedure: 10 ml of venous blood taken from the patients will be put into the T-LAB® PRP kit (T-Biotechnology Laboratory, İstanbul, Turkey) and will then be centrifuged. Approximately 3 cc of the PRP obtained will be applied to the tendinosis area under USG guidance. All injections will be performed with long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).

PRP+ESWT+Exercise

Radial ESWT treatment will be applied to patients for 3 weeks, once a week for a total of 3 sessions. Radial shock waves will be applied in circular motions by applying gel on the epicondylar area where the most pain and sensitivity is. In each session, 8 Hz, 2.0 bar, 2000 beats will be applied. Therapeutic Exercise: All patients will be taught aforementioned home exercise program. Exercise program will be done twice a day for 3 months. Procedure: In Sham-PRP group,10 ml of venous blood will be taken and after the same waiting time 3 cc of 0.9% saline will be injected to the tendinosis area under USG guidance. All injections will be performed with long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).

Sham PRP+ESWT+Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with lateral epicondylitis after physical examination
  • No other pathology detected on direct radiography
  • Complaints persisting for more than 3 months despite the application of other conservative treatment methods
  • Patients accepting to give blood for PRP or sham injection and can tolerate elbow injection and extracorporeal shock wave therapy (ESWT)

You may not qualify if:

  • Not being able to fully cooperate with the study and inability to read and write,
  • Injection (corticosteroid, PRP, etc.) treatment applied to the elbow area within three months,
  • Previous surgery or ESWT treatment in the area to be treated,
  • Pregnant women,
  • Arthritis (rheumatoid arthritis, spondyloarthritis, crystal arthropathies),
  • Those who have a history of direct trauma to the elbow and a history of fracture,
  • Those with a history of malignancy,
  • Bleeding diathesis,
  • Complex regional pain syndrome,
  • Presence of acute systemic infection,
  • Presence of local infection at the injection site,
  • Peripheral vasculopathy,
  • Cervical radiculopathy,
  • Patients with contraindications to ESWT application (pregnancy, cancer, coagulation disorders, inflammatory disease, pacemaker, metal implant in the area to be applied) were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Afyonkarahisar Health Sciences University

Afyonkarahisar, 03200, Turkey (Türkiye)

Location

Related Publications (4)

  • Gunduz R, Malas FU, Borman P, Kocaoglu S, Ozcakar L. Physical therapy, corticosteroid injection, and extracorporeal shock wave treatment in lateral epicondylitis. Clinical and ultrasonographical comparison. Clin Rheumatol. 2012 May;31(5):807-12. doi: 10.1007/s10067-012-1939-y. Epub 2012 Jan 27.

    PMID: 22278162BACKGROUND
  • Alessio-Mazzola M, Repetto I, Biti B, Trentini R, Formica M, Felli L. Autologous US-guided PRP injection versus US-guided focal extracorporeal shock wave therapy for chronic lateral epicondylitis: A minimum of 2-year follow-up retrospective comparative study. J Orthop Surg (Hong Kong). 2018 Jan-Apr;26(1):2309499017749986. doi: 10.1177/2309499017749986.

    PMID: 29320964BACKGROUND
  • Arirachakaran A, Sukthuayat A, Sisayanarane T, Laoratanavoraphong S, Kanchanatawan W, Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol. 2016 Jun;17(2):101-12. doi: 10.1007/s10195-015-0376-5. Epub 2015 Sep 11.

    PMID: 26362783BACKGROUND
  • Akcin AI, Eyvaz N, Dundar U, Toktas H, Yesil H, Eroglu S, Adar S. The Clinical Efficacy of Extracorporeal Shock Wave Therapy Combined With Platelet-Rich Plasma and Exercise for Lateral Epicondylitis: Prospective Randomized Sham-Controlled Ultrasonographic Study. Arch Phys Med Rehabil. 2025 Aug;106(8):1173-1182. doi: 10.1016/j.apmr.2025.01.420. Epub 2025 Jan 20.

MeSH Terms

Conditions

Musculoskeletal DiseasesTennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Officials

  • Nuran EYVAZ, MD

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR
  • Ali İzzet AKÇİN, MD

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator-Research Assistant-MD

Study Record Dates

First Submitted

October 27, 2022

First Posted

November 2, 2022

Study Start

October 15, 2022

Primary Completion

December 20, 2023

Study Completion

January 10, 2024

Last Updated

January 7, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations